M12 M1 Kliniken AG
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.…
Industry Peers
Medical DistributionKey Statistics
About M1 Kliniken (ETR: M12)
›
M1 Kliniken (ETR: M12) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 280 employees.
The shares were at 18.62 EUR on 20 November 2026, up 19.8% over 52 weeks. Its 52-week range is 13.62 EUR to 21.70 EUR: the price is 14.2% below the high and 36.7% above the low.
At a market capitalisation of 345.50M EUR, it trades at 17.9 times trailing earnings and 16.6 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 22.9, a discount of 22% for M12. It pays a dividend yielding 6.29% (it pays out 49% of its earnings), against a median of 1.38% among the dividend payers in that peer group.
M1 Kliniken reports return on equity of 18.5%, an operating margin of 12.4% and revenue down 58.3% year over year.
It holds more cash than debt, a net cash position of 54.59M EUR. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health.